Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

New and improved: Hospital updates AFib ablation protocols, improves efficiency

“Value can be defined as delivered care divided by cost,” the specialists wrote. “Ideally, each patient receives the same good quality of care in an equitable, timely way.”

Study confirms COVID-19 vaccines are effective

A new study has confirmed vaccines from Pfizer-BioNTech and Moderna are effective at preventing symptomatic COVID-19 cases.

Thumbnail

TMVR safe and effective for kidney transplant recipients

One important detail, however, was that acute kidney injury was more common for kidney transplant recipients. The researchers listed numerous potential explanations for this trend.

Thumbnail

Working long hours increases the likelihood of a second heart attack

The analysis, published in the Journal of the American College of Cardiology, tracked nearly 1,000 patients treated for their first myocardial infarction from November 1995 to October 1997.

‘A new treatment option’: FDA approves Harmony TPV, says it could delay the need for certain surgeries

The solution’s approval was based on 30-day and six-month data from a clinical study focused on mortality and hemodynamic function.

FDA approves Zealand Pharma’s new treatment for severe hypoglycemia

The injection, being marketed as Zegalogue, will be made available in an auto injector or a prefilled syringe.

Thumbnail

PTSD linked to a higher risk of heart attack, heart disease among female veterans

The association between PTSD and ischemic heart disease was especially strong for younger veterans. 

Championing Alternative PAD Access in the Office-based Lab

Sponsored by Terumo

Improving access is at the center of a pair of new trends in treating peripheral artery disease (PAD). First is the office-based lab (OBL) expanding access to more PAD patients needing therapy, and the second is physicians more often choosing alternative access such as radial, tibial or pedal to treat those patients. Why now?